CN101947318A - 一种猪细小病毒灭活疫苗的制备方法 - Google Patents
一种猪细小病毒灭活疫苗的制备方法 Download PDFInfo
- Publication number
- CN101947318A CN101947318A CN2010102775020A CN201010277502A CN101947318A CN 101947318 A CN101947318 A CN 101947318A CN 2010102775020 A CN2010102775020 A CN 2010102775020A CN 201010277502 A CN201010277502 A CN 201010277502A CN 101947318 A CN101947318 A CN 101947318A
- Authority
- CN
- China
- Prior art keywords
- cell
- cells
- ibrs
- pig parvoviral
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940031551 inactivated vaccine Drugs 0.000 title claims abstract description 37
- 241000702619 Porcine parvovirus Species 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title abstract description 7
- 241000700605 Viruses Species 0.000 claims abstract description 33
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 230000002779 inactivation Effects 0.000 claims abstract description 5
- 238000011084 recovery Methods 0.000 claims abstract description 4
- 229960005486 vaccine Drugs 0.000 claims description 51
- 210000002966 serum Anatomy 0.000 claims description 21
- 230000003612 virological effect Effects 0.000 claims description 21
- 238000011081 inoculation Methods 0.000 claims description 16
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 14
- 239000001963 growth medium Substances 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 238000011534 incubation Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 238000004043 dyeing Methods 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims 1
- 230000012010 growth Effects 0.000 abstract description 9
- 239000000969 carrier Substances 0.000 abstract 3
- 238000012258 culturing Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 76
- 241000282898 Sus scrofa Species 0.000 description 53
- 238000012360 testing method Methods 0.000 description 40
- 230000036039 immunity Effects 0.000 description 23
- 231100000614 poison Toxicity 0.000 description 17
- 241000700199 Cavia porcellus Species 0.000 description 15
- 230000005847 immunogenicity Effects 0.000 description 11
- 239000002574 poison Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000009395 breeding Methods 0.000 description 8
- 230000001488 breeding effect Effects 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 230000001018 virulence Effects 0.000 description 8
- 238000010241 blood sampling Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 6
- 239000000273 veterinary drug Substances 0.000 description 6
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 5
- 230000009849 deactivation Effects 0.000 description 5
- 230000003053 immunization Effects 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000710777 Classical swine fever virus Species 0.000 description 3
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000012297 crystallization seed Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000009781 safety test method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 101100129922 Caenorhabditis elegans pig-1 gene Proteins 0.000 description 1
- 101100520057 Drosophila melanogaster Pig1 gene Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000204003 Mycoplasmatales Species 0.000 description 1
- 206010034098 Parvoviral infections Diseases 0.000 description 1
- 208000008071 Parvoviridae Infections Diseases 0.000 description 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010058874 Viraemia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 230000003067 hemagglutinative effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000000937 inactivator Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- -1 stearic acid aluminum Chemical compound 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102775020A CN101947318B (zh) | 2010-09-09 | 2010-09-09 | 一种猪细小病毒灭活疫苗的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102775020A CN101947318B (zh) | 2010-09-09 | 2010-09-09 | 一种猪细小病毒灭活疫苗的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101947318A true CN101947318A (zh) | 2011-01-19 |
CN101947318B CN101947318B (zh) | 2012-09-05 |
Family
ID=43451026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102775020A Expired - Fee Related CN101947318B (zh) | 2010-09-09 | 2010-09-09 | 一种猪细小病毒灭活疫苗的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101947318B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102091329A (zh) * | 2011-01-30 | 2011-06-15 | 哈药集团生物疫苗有限公司 | 猪细小病毒灭活疫苗的制备方法及其产品 |
CN102688485A (zh) * | 2011-09-16 | 2012-09-26 | 扬州优邦生物制药有限公司 | 一种猪细小病毒灭活疫苗的制备方法 |
CN102861329A (zh) * | 2012-09-19 | 2013-01-09 | 武汉中博生物股份有限公司 | 一种利用生物反应器生产犬细小病毒灭活疫苗的方法 |
CN102988972A (zh) * | 2012-12-14 | 2013-03-27 | 山东滨州沃华生物工程有限公司 | 一种运用激流式生物反应器生产猪细小病毒灭活疫苗的方法 |
CN103157106A (zh) * | 2012-12-27 | 2013-06-19 | 瑞普(保定)生物药业有限公司 | 一种制备猪细小病毒病灭活疫苗的方法 |
CN103877573A (zh) * | 2014-03-21 | 2014-06-25 | 吉林正业生物制品股份有限公司 | 伪狂犬病活疫苗的制备方法及其产品 |
CN103877572A (zh) * | 2014-03-21 | 2014-06-25 | 吉林正业生物制品股份有限公司 | 猪细小病毒病灭活疫苗的制备方法 |
CN104812893A (zh) * | 2012-11-22 | 2015-07-29 | 旭化成医疗株式会社 | 高感染滴度的细小病毒的生产方法 |
CN107496913A (zh) * | 2017-09-15 | 2017-12-22 | 天津瑞普生物技术股份有限公司 | 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法 |
CN107648599A (zh) * | 2017-09-18 | 2018-02-02 | 天津瑞普生物技术股份有限公司 | 一种猪丹毒、猪细小病毒二联灭活疫苗的制备方法 |
CN107686833A (zh) * | 2016-04-18 | 2018-02-13 | 华南农业大学 | 一种猪细小病毒毒株及其应用 |
CN111269808A (zh) * | 2020-02-17 | 2020-06-12 | 英诺维尔智能科技(苏州)有限公司 | 高污染高传染风险生物样本安全检测自动化方法 |
CN113073087A (zh) * | 2021-03-18 | 2021-07-06 | 武汉科前生物股份有限公司 | 一种纯化猪轮状病毒的方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311690A (zh) * | 1998-07-06 | 2001-09-05 | 梅瑞尔公司 | 猪环状病毒和细小病毒疫苗 |
CN101745106A (zh) * | 2008-12-09 | 2010-06-23 | 上海佳牧生物制品有限公司 | 一种猪细小病毒病活疫苗及其制备方法 |
-
2010
- 2010-09-09 CN CN2010102775020A patent/CN101947318B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311690A (zh) * | 1998-07-06 | 2001-09-05 | 梅瑞尔公司 | 猪环状病毒和细小病毒疫苗 |
CN101745106A (zh) * | 2008-12-09 | 2010-06-23 | 上海佳牧生物制品有限公司 | 一种猪细小病毒病活疫苗及其制备方法 |
Non-Patent Citations (2)
Title |
---|
L. MARANGA, ET AL.: "Large scale production and downstream processing of a recombinant porcine parvovirus vaccine", 《APPL MICROBIOL BIOTECHNOL》 * |
潘雪珠等: "猪细小病毒灭活疫苗研究(简报)", 《上海畜牧兽医通讯》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102091329B (zh) * | 2011-01-30 | 2013-08-07 | 哈药集团生物疫苗有限公司 | 猪细小病毒灭活疫苗的制备方法及其产品 |
CN102091329A (zh) * | 2011-01-30 | 2011-06-15 | 哈药集团生物疫苗有限公司 | 猪细小病毒灭活疫苗的制备方法及其产品 |
CN102688485A (zh) * | 2011-09-16 | 2012-09-26 | 扬州优邦生物制药有限公司 | 一种猪细小病毒灭活疫苗的制备方法 |
CN102861329A (zh) * | 2012-09-19 | 2013-01-09 | 武汉中博生物股份有限公司 | 一种利用生物反应器生产犬细小病毒灭活疫苗的方法 |
CN104812893A (zh) * | 2012-11-22 | 2015-07-29 | 旭化成医疗株式会社 | 高感染滴度的细小病毒的生产方法 |
CN102988972A (zh) * | 2012-12-14 | 2013-03-27 | 山东滨州沃华生物工程有限公司 | 一种运用激流式生物反应器生产猪细小病毒灭活疫苗的方法 |
CN102988972B (zh) * | 2012-12-14 | 2014-05-28 | 山东滨州沃华生物工程有限公司 | 一种运用激流式生物反应器生产猪细小病毒灭活疫苗的方法 |
CN103157106A (zh) * | 2012-12-27 | 2013-06-19 | 瑞普(保定)生物药业有限公司 | 一种制备猪细小病毒病灭活疫苗的方法 |
CN103877573A (zh) * | 2014-03-21 | 2014-06-25 | 吉林正业生物制品股份有限公司 | 伪狂犬病活疫苗的制备方法及其产品 |
CN103877572A (zh) * | 2014-03-21 | 2014-06-25 | 吉林正业生物制品股份有限公司 | 猪细小病毒病灭活疫苗的制备方法 |
CN107686833A (zh) * | 2016-04-18 | 2018-02-13 | 华南农业大学 | 一种猪细小病毒毒株及其应用 |
CN107496913A (zh) * | 2017-09-15 | 2017-12-22 | 天津瑞普生物技术股份有限公司 | 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法 |
CN107648599A (zh) * | 2017-09-18 | 2018-02-02 | 天津瑞普生物技术股份有限公司 | 一种猪丹毒、猪细小病毒二联灭活疫苗的制备方法 |
CN111269808A (zh) * | 2020-02-17 | 2020-06-12 | 英诺维尔智能科技(苏州)有限公司 | 高污染高传染风险生物样本安全检测自动化方法 |
CN113073087A (zh) * | 2021-03-18 | 2021-07-06 | 武汉科前生物股份有限公司 | 一种纯化猪轮状病毒的方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101947318B (zh) | 2012-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101947318B (zh) | 一种猪细小病毒灭活疫苗的制备方法 | |
CN101979518B (zh) | 一种制备伪狂犬病病毒的方法 | |
CN101773667A (zh) | 一种猪圆环病毒ii型疫苗制备 | |
CN104258385B (zh) | Bhk-21细胞全悬浮培养技术在新城疫疫苗生产中的应用 | |
CN101665781B (zh) | 高滴度猪圆环病毒2型培养细胞、制备方法及其用法 | |
CN101955915B (zh) | 一种流感病毒疫苗的生产方法 | |
CN101926991A (zh) | 猪瘟病毒疫苗及其生产方法 | |
CN102205120B (zh) | 一种猪细小病毒灭活疫苗的生产方法 | |
CN102988972B (zh) | 一种运用激流式生物反应器生产猪细小病毒灭活疫苗的方法 | |
CN104946600A (zh) | 一种h9亚型禽流感病毒株 | |
CN105749270A (zh) | 轮状病毒疫苗及其制备方法 | |
CN105582533A (zh) | 一种禽流感病毒、禽腺病毒二联灭活疫苗 | |
CN103520715B (zh) | 利用wave波浪生物反应器生产猪圆环病毒2型灭活疫苗的方法 | |
CN105535958B (zh) | 一种鸡新城疫病毒、传染性支气管炎、禽腺病毒三联灭活疫苗 | |
CN102886043B (zh) | 猪乙型脑炎病毒与猪细小病毒二联灭活疫苗及其制备方法 | |
CN102727878A (zh) | 一种生物反应器制备猪繁殖与呼吸综合征灭活疫苗(nvdc-jxa1株)的方法及其应用 | |
CN103143009A (zh) | 一种大规模生产鸭坦布苏病毒灭活疫苗的方法 | |
CN102580079A (zh) | 猪细小病毒纳米铝胶佐剂灭活疫苗及其制备方法 | |
CN108421037A (zh) | 一种猪伪狂犬病/猪细小病毒病二联灭活疫苗及其悬浮培养制备方法 | |
CN107823639A (zh) | 牛病毒性腹泻病毒灭活疫苗及其制备方法 | |
CN102965345B (zh) | 猪细小病毒、疫苗组合物及其应用 | |
CN102166355A (zh) | 一种用于预防鸡疾病的四联灭活疫苗 | |
CN106367399B (zh) | 一种使用全悬浮技术生产猪细小病毒病疫苗的方法 | |
CN103157106B (zh) | 一种制备猪细小病毒病灭活疫苗的方法 | |
CN101905019A (zh) | 一种猪血凝性脑脊髓炎细胞培养灭活疫苗及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: VACBIO CO., LTD. Free format text: FORMER OWNER: YANGZHOU VAC BIO ENGINEERING CO., LTD. Effective date: 20130315 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130315 Address after: 225008 No. 7 Huai Road, Weiyang Economic Development Zone, Jiangsu, Yangzhou Patentee after: YANGZHOU YOUBANG BIO-CHEMICAL PHARMACEUTIAL Co.,Ltd. Patentee after: SINOPHARM YANGZHOU VAC BIOLOGICAL ENGINEERING CO.,LTD. Address before: 225008 Jin Huai Road, Weiyang Economic Development Zone, Yangzhou, Jiangsu Patentee before: YANGZHOU YOUBANG BIO-CHEMICAL PHARMACEUTIAL Co.,Ltd. Patentee before: YANGZHOU VAC BIO ENGINEERING Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 225000 Jinhuai Road, Weiyang Economic Development Zone, Yangzhou City, Jiangsu Province Co-patentee after: SINOPHARM YANGZHOU VAC BIOLOGICAL ENGINEERING CO.,LTD. Patentee after: YANGZHOU UNI-BIO PHARMACEUTICAL Co.,Ltd. Address before: 225008 No. 7 Jinhuai Road, Weiyang Economic Development Zone, Yangzhou City, Jiangsu Province Co-patentee before: SINOPHARM YANGZHOU VAC BIOLOGICAL ENGINEERING CO.,LTD. Patentee before: YANGZHOU YOUBANG BIO-CHEMICAL PHARMACEUTIAL Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120905 Termination date: 20210909 |
|
CF01 | Termination of patent right due to non-payment of annual fee |